Other OTC Pharmaceuticals (Pharmacies) - Russia

  • Russia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$1.54bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.77%, resulting in a market volume of US$1.60bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$10.71 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Russia is experiencing significant growth and development.

Customer preferences:
Customers in Russia have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing medications without a prescription and the increasing awareness of self-care and self-medication. Additionally, the affordability of OTC drugs compared to prescription medications has also contributed to the popularity of this market segment.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Russia is the growing demand for preventive healthcare products. Consumers are becoming more proactive in managing their health and are seeking products that can help prevent common ailments and promote overall well-being. This trend is driving the sales of vitamins, dietary supplements, and other preventive healthcare products in pharmacies across the country. Another trend in the market is the increasing availability of OTC pharmaceutical products online. E-commerce platforms have gained popularity in Russia, and consumers are now able to conveniently purchase OTC drugs and healthcare products from the comfort of their homes. This has opened up new opportunities for pharmacies to expand their reach and cater to a larger customer base.

Local special circumstances:
Russia has a well-established network of pharmacies, with both independent and chain pharmacies operating across the country. This extensive pharmacy network ensures easy access to OTC pharmaceutical products for consumers in urban as well as rural areas. Moreover, the Russian government has implemented regulations to ensure the quality and safety of OTC drugs, which further instills confidence in consumers when purchasing these products.

Underlying macroeconomic factors:
The growing middle class in Russia has contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. As disposable incomes increase, consumers are willing to spend more on healthcare and wellness products, including OTC pharmaceuticals. Additionally, the aging population in Russia is driving the demand for OTC drugs, as older individuals often require medications for chronic conditions that can be managed with OTC products. Furthermore, the Russian government has been actively promoting self-care and self-medication as a means to reduce the burden on the healthcare system. This has led to increased awareness and acceptance of OTC pharmaceuticals among consumers. The government's focus on preventive healthcare and wellness initiatives has also played a role in the growth of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Russia is witnessing significant growth driven by customer preferences for convenient and affordable healthcare products. The market is characterized by the increasing demand for preventive healthcare products and the availability of OTC drugs online. The well-established pharmacy network, government regulations, and underlying macroeconomic factors such as the growing middle class and aging population are further contributing to the development of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)